Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition

Dyck, 1975, Chronic inflammatory polyradiculoneuropathy, Mayo Clin Proc, 50, 621 Vallat, 2003, Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases, Muscle Nerve, 27, 478, 10.1002/mus.10348 Burns, 2004, Chronic inflammatory demyelinating polyradiculoneuropathy, Arch Neurol, 61, 973, 10.1001/archneur.61.6.973 Austin, 1958, Recurrent polyneuropathies and their corticosteroid treatment, Brain, 81, 11, 10.1093/brain/81.2.157 Lewis, 1982, The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies, Neurology, 32, 592, 10.1212/WNL.32.6.592 Dyck, 1982, Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment, Ann Neurol, 11, 136, 10.1002/ana.410110205 1991, Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP), Neurology, 41, 617, 10.1212/WNL.41.5.617 Hughes, 2001, Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 50, 195, 10.1002/ana.1088 2005, Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society, J Peripher Nerv Syst, 10, 220, 10.1111/j.1085-9489.2005.10302.x Nicolas, 2002, Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 25, 26, 10.1002/mus.1214 Van den Bergh, 2004, Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 29, 565, 10.1002/mus.20022 2008, Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy, J Neurol Neurosurg Psychiatry, 79, 115 Rajabally, 2009, Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population, Muscle Nerve, 39, 432, 10.1002/mus.21206 Magy, 2009, Evidence-based treatment of chronic immune-mediated neuropathies, Expert Opin Pharmacother, 10, 1741, 10.1517/14656560903036095 Lunn, 1999, Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England, J Neurol Neurosurg Psychiatry, 66, 677, 10.1136/jnnp.66.5.677 Mygland, 2001, Chronic polyneuropathies in Vest-Agder, Norway, Eur J Neurol, 8, 157, 10.1046/j.1468-1331.2001.00187.x Iijima, 2008, Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population, J Neurol Neurosurg Psychiatry, 79, 1040, 10.1136/jnnp.2007.128132 Koller, 2005, Chronic inflammatory demyelinating polyneuropathy—update on pathogenesis, diagnostic criteria and therapy, Curr Opin Neurol, 18, 273, 10.1097/01.wco.0000169744.14288.d1 Bosboom, 2001, Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy, Neurology, 56, 74, 10.1212/WNL.56.1.74 Winer, 2002, Gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy, J Neurol, 249, 616, 10.1007/s004150200072 Hartung, 1991, Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis, Ann Neurol, 30, 48, 10.1002/ana.410300110 Misawa, 2001, Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy, Neurology, 56, 666, 10.1212/WNL.56.5.666 Kieseier, 2002, Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10, Brain, 125, 823, 10.1093/brain/awf070 Mahad, 2002, Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy, J Neurol Neurosurg Psychiatry, 73, 320, 10.1136/jnnp.73.3.320 Maimone, 1993, Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy, J Neuroimmunol, 47, 55, 10.1016/0165-5728(93)90284-6 Oka, 1994, Expression of endothelial leukocyte adhesion molecule-1 (ELAM-1) in chronic inflammatory demyelinating polyneuropathy, Neurology, 44, 946, 10.1212/WNL.44.5.946 Kanda, 2004, Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1, J Neurol Neurosurg Psychiatry, 75, 765, 10.1136/jnnp.2003.025692 Van Rhijn, 2000, Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy, Brain, 123, 2020, 10.1093/brain/123.10.2020 Comi, 2006, Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy, J Peripher Nerv Syst, 11, 53, 10.1111/j.1085-9489.2006.00063.x Chi, 2008, Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy, J Peripher Nerv Syst, 13, 54, 10.1111/j.1529-8027.2008.00158.x Notturno, 2008, Susceptibility to chronic inflammatory demyelinating polyradiculoneuropathy is associated to polymorphic GA repeat in the SH2D2A gene, J Neuroimmunol, 197, 124, 10.1016/j.jneuroim.2008.04.003 Kiefer, 2000, Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies, J Neurol Neurosurg Psychiatry, 69, 362, 10.1136/jnnp.69.3.362 Murata, 2000, Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy, Brain, 123, 1660, 10.1093/brain/123.8.1660 Salomon, 2001, Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice, J Exp Med, 194, 677, 10.1084/jem.194.5.677 Hu, 2007, Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies, Neurology, 68, 277, 10.1212/01.wnl.0000250240.99311.9d Sommer, 2005, Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP, Neurology, 65, 1924, 10.1212/01.wnl.0000188879.19900.b7 Vital, 2000, Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases, Ultrastruct Pathol, 24, 363, 10.1080/019131200750060023 Kawasaki, 2001, Up-regulation of cyclooxygenase-2 in inflammatory demyelinating neuropathy, Acta Neuropathol, 101, 154, 10.1007/s004010000279 Dalakas, 1980, Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy, Arch Neurol, 37, 637, 10.1001/archneur.1980.00500590061010 Koski, 1985, Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum an antibody by complement component 1 fixation, Proc Natl Acad Sci USA, 82, 905, 10.1073/pnas.82.3.905 Tagawa, 2000, Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy, Muscle Nerve, 23, 895, 10.1002/(SICI)1097-4598(200006)23:6<895::AID-MUS8>3.0.CO;2-G Yan, 2001, P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 50, 286, 10.1002/ana.1129 Yan, 2000, Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients, Ann Neurol, 47, 765, 10.1002/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8 Kim, 2008, Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy, J Immunol, 181, 8753, 10.4049/jimmunol.181.12.8753 Sanvito, 2009, Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy, J Neurol Neurosurg Psychiatry, 80, 333, 10.1136/jnnp.2008.159798 Tackenberg, 2009, Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy, Proc Natl Acad Sci USA, 106, 4788, 10.1073/pnas.0807319106 Gorson, 1997, Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy, Neurology, 48, 321, 10.1212/WNL.48.2.321 Maisonobe, 1996, Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients, J Neurol Neurosurg Psychiatry, 61, 36, 10.1136/jnnp.61.1.36 Busby, 2003, Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients, J Neurol, 250, 714, 10.1007/s00415-003-1068-2 Sabatelli, 2001, Pure motor chronic inflammatory demyelinating polyneuropathy, J Neurol, 248, 772, 10.1007/s004150170093 Berger, 1995, Late motor involvement in cases presenting as “chronic sensory demyelinating polyneuropathy”, Muscle Nerve, 18, 440, 10.1002/mus.880180411 Oh, 1992, “Chronic sensory demyelinating neuropathy”: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy, J Neurol Neurosurg Psychiatry, 55, 677, 10.1136/jnnp.55.8.677 Boukhris, 2005, Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases, J Peripher Nerv Syst, 10, 329, 10.1111/j.1085-9489.2005.10311.x Uncini, 1999, Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy, Clin Neurophysiol, 110, 694, 10.1016/S1388-2457(98)00070-4 Lewis, 1982, Multifocal demyelinating neuropathy with persistent conduction block, Neurology, 32, 958, 10.1212/WNL.32.9.958 Saperstein, 1999, Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome, Muscle Nerve, 22, 560, 10.1002/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q Oh, 1997, Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy?, J Peripher Nerv Syst, 2, 362 Oh, 2005, Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy, Neurology, 65, 1639, 10.1212/01.wnl.0000184592.54972.5e Katz, 2000, Distal acquired demyelinating symmetric neuropathy, Neurology, 54, 615, 10.1212/WNL.54.3.615 Mygland, 2003, Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness, Arch Neurol, 60, 260, 10.1001/archneur.60.2.260 Sinnreich, 2004, Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia, Neurology, 63, 1662, 10.1212/01.WNL.0000142507.12763.58 Van den Berg-Vos, 2000, Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?, Neurology, 54, 26, 10.1212/WNL.54.1.26 Dyck, 2000, Atypical varieties of chronic inflammatory demyelinating neuropathies, Lancet, 355, 1293, 10.1016/S0140-6736(00)02109-7 Stewart, 1996, Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics, J Neurol Sci, 142, 59, 10.1016/0022-510X(96)00126-8 Uncini, 1999, Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy, Clin Neurophysiol, 110, 705, 10.1016/S1388-2457(98)00028-5 Laughlin, 2009, Incidence and prevalence of CIDP and the association of diabetes mellitus, Neurology, 73, 39, 10.1212/WNL.0b013e3181aaea47 Hawke, 1990, Cranial magnetic resonance imaging in chronic demyelinating polyneuropathy, J Neurol Neurosurg Psychiatry, 53, 794, 10.1136/jnnp.53.9.794 Mendell, 1987, Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy, Neurology, 37, 1291, 10.1212/WNL.37.8.1291 Sharma, 2008, Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis, J Clin Neuromuscul Dis, 9, 385, 10.1097/CND.0b013e31816f18e3 Ginsberg, 2004, Coexistent hereditary and inflammatory neuropathy, Brain, 127, 193, 10.1093/brain/awh017 Dyck, 1982, Prednisone-responsive hereditary motor and sensory neuropathy, Mayo Clin Proc, 57, 239 Nevo, 1996, Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up, Neurology, 47, 98, 10.1212/WNL.47.1.98 Ryan, 2000, Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome, Neuromuscul Disord, 10, 398, 10.1016/S0960-8966(00)00119-X Simmons, 1997, Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults, Muscle Nerve, 20, 1008, 10.1002/(SICI)1097-4598(199708)20:8<1008::AID-MUS11>3.0.CO;2-R Simmons, 1997, Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults, Muscle Nerve, 20, 1569, 10.1002/(SICI)1097-4598(199712)20:12<1569::AID-MUS12>3.0.CO;2-W Oh, 2003, Subacute inflammatory demyelinating polyneuropathy, Neurology, 61, 1507, 10.1212/01.WNL.0000096166.28131.4C McCombe, 1987, Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases, Brain, 110, 1617, 10.1093/brain/110.6.1617 Mori, 2002, Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS, Neurology, 58, 979, 10.1212/WNL.58.6.979 Odaka, 2003, Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome, J Neurol, 250, 913, 10.1007/s00415-003-1096-y Ruts, 2005, Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations, Neurology, 65, 138, 10.1212/01.wnl.0000167549.09664.b8 Dionne, 2010, Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy, Muscle Nerve, 41, 202, 10.1002/mus.21480 Bouchard, 1999, Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy, Neurology, 52, 498, 10.1212/WNL.52.3.498 Tackenberg, 2007, Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy, Neurology, 68, 1622, 10.1212/01.wnl.0000260972.07422.ea Rajabally, 2006, Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy, Clin Neurophysiol, 117, 2079, 10.1016/j.clinph.2006.05.028 Albers, 1989, Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features, Muscle Nerve, 12, 435, 10.1002/mus.880120602 Magda, 2003, Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy, Arch Neurol, 60, 1755, 10.1001/archneur.60.12.1755 Saperstein, 2001, Clinical spectrum of chronic acquired demyelinating polyneuropathies, Muscle Nerve, 24, 311, 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A Thaisetthawatkul, 2002, Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy, Neurology, 59, 1526, 10.1212/01.WNL.0000034172.47882.20 Rajabally, 2005, Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases, J Peripher Nerv Syst, 10, 282, 10.1111/j.1085-9489.2005.10306.x Koski, 2009, Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy, J Neurol Sci, 277, 1, 10.1016/j.jns.2008.11.015 Rajabally, 2009, Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study, J Neurol Neurosurg Psychiatry, 80, 1364, 10.1136/jnnp.2009.179358 Feasby, 1996, Axonal CIDP: a premature concept?, Muscle Nerve, 19, 372, 10.1002/(SICI)1097-4598(199603)19:3<372::AID-MUS15>3.0.CO;2-U Harbo, 2008, Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 38, 1036, 10.1002/mus.21000 Uncini, 1996, Chronic progressive steroid responsive axonal polyneuropathy: a CIDP vaariant or a primary axonal disorder?, Muscle Nerve, 19, 365, 10.1002/(SICI)1097-4598(199603)19:3<365::AID-MUS14>3.0.CO;2-R Yiannikas, 2008, Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy, Muscle Nerve, 38, 1447, 10.1002/mus.21078 Crino, 1993, Magnetic resonance imaging of the cauda equina in chronic inflammatory demyelinating polyneuropathy, Ann Neurol, 33, 311, 10.1002/ana.410330314 Duggins, 1999, Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy, Brain, 122, 1383, 10.1093/brain/122.7.1383 Goldstein, 1996, Nerve root hypertrophy as the cause of lumbar stenosis in chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 19, 892, 10.1002/(SICI)1097-4598(199607)19:7<892::AID-MUS12>3.0.CO;2-L Bradley, 2006, Brachial plexus hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy, Neuromuscul Disord, 16, 126, 10.1016/j.nmd.2005.11.006 Midroni, 1996, Chronic inflammatory demyelinating polyradiculoneuropathy: unusual clinical features and therapeutic responses, Neurology, 46, 1206, 10.1212/WNL.46.5.1206 Tsuchiya, 2008, Demonstration of spinal cord and nerve root abnormalities by diffusion neurography, J Comput Assist Tomogr, 32, 286, 10.1097/RCT.0b013e31814625e3 Chiang, 2002, Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy, Neurology, 59, 1094, 10.1212/WNL.59.7.1094 Gibbels, 1990, Unmyelinated fibers in sural nerve biopsies of chronic inflammatory demyelinating polyneuropathy, Acta Neuropathol, 80, 439, 10.1007/BF00307700 Vallat, 1996, Link between peripheral neuropathy and monoclonal dysglobulinemia: a study of 66 cases, J Neurol Sci, 137, 124, 10.1016/0022-510X(95)00343-Z Gorson, 2002, Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy, Arch Neurol, 59, 766, 10.1001/archneur.59.5.766 Magy, 2003, Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases, Eur J Neurol, 10, 677, 10.1046/j.1468-1331.2003.00687.x Smith, 1994, The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study, Brain, 117, 949, 10.1093/brain/117.5.949 Chassande, 1998, Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases, Muscle Nerve, 21, 55, 10.1002/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F Nobile-Orazio, 2000, Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies, Brain, 123, 710, 10.1093/brain/123.4.710 Ropert, 1990, Conduction block in neuropathies with necrotizing vasculitis, Muscle Nerve, 13, 102, 10.1002/mus.880130203 Kelly, 1983, Osteosclerotic myeloma and peripheral neuropathy, Neurology, 33, 202, 10.1212/WNL.33.2.202 Jaccard, 2002, High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome, Blood, 99, 3057, 10.1182/blood.V99.8.3057 Vital, 1994, Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients, Acta Neuropathol, 87, 302, 10.1007/BF00296746 Nobile-Orazio, 2009, Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies, Neurology, 72, 1024, 10.1212/01.wnl.0000344569.13496.ff Plante-Bordeneuve, 2007, Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP), Neurology, 69, 693, 10.1212/01.wnl.0000267338.45673.f4 Chin, 2004, Sensory CIDP presenting as cryptogenic sensory polyneuropathy, J Peripher Nerv Syst, 9, 132, 10.1111/j.1085-9489.2004.09302.x Simmons, 1995, Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy, Brain, 118, 359, 10.1093/brain/118.2.359 Molenaar, 1997, Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study, J Neurol Neurosurg Psychiatry, 62, 388, 10.1136/jnnp.62.4.388 Muley, 2008, Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids, Arch Neurol, 65, 1460, 10.1001/archneur.65.11.1460 Nobile-Orazio, 2005, Treatment of dys-immune neuropathies, J Neurol, 252, 385, 10.1007/s00415-005-0805-0 Hahn, 1998, Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin, Neurology, 51, S16, 10.1212/WNL.51.6_Suppl_5.S16 Mendell, 2001, Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy, Neurology, 56, 445, 10.1212/WNL.56.4.445 Thompson, 1996, A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy, J Neurol, 243, 280, 10.1007/BF00868527 Vermeulen, 1993, Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study, J Neurol Neurosurg Psychiatry, 56, 36, 10.1136/jnnp.56.1.36 Dyck, 1994, A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 36, 838, 10.1002/ana.410360607 van Doorn, 1990, High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study, Neurology, 40, 209, 10.1212/WNL.40.2.209 Hughes, 2008, Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial, Lancet Neurol, 7, 136, 10.1016/S1474-4422(07)70329-0 Dyck, 1986, Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy, N Engl J Med, 314, 461, 10.1056/NEJM198602203140801 Hahn, 1996, Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study, Brain, 119, 1055, 10.1093/brain/119.4.1055 Mehndiratta, 2004, Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD003906.pub2 Hughes, 2004, Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD003280.pub2 Dyck, 1985, Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy, Neurology, 35, 1173, 10.1212/WNL.35.8.1173 Brannagan, 2002, High-dose cyclophosphamide without stem-cell rescue for refractory CIDP, Neurology, 58, 1856, 10.1212/WNL.58.12.1856 Gladstone, 2005, High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy, J Peripher Nerv Syst, 10, 11, 10.1111/j.1085-9489.2005.10104.x Good, 1998, Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy, Neurology, 51, 1735, 10.1212/WNL.51.6.1735 Vermeulen, 2002, Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy, J Neurol Neurosurg Psychiatry, 72, 127, 10.1136/jnnp.72.1.127 Gorson, 2004, Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy, Neurology, 63, 715, 10.1212/01.WNL.0000134676.05850.C0 Radziwill, 2006, Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: an open-label study, Eur Neurol, 56, 37, 10.1159/000095139 2009, Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study, Lancet Neurol, 8, 158, 10.1016/S1474-4422(08)70299-0 Barnett, 1998, Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy, Muscle Nerve, 21, 454, 10.1002/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8 Odaka, 2005, Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin, J Neurol Neurosurg Psychiatry, 76, 1115, 10.1136/jnnp.2003.035428 Briani, 2004, Rituximab-responsive CIDP, Eur J Neurol, 11, 788, 10.1111/j.1468-1331.2004.00911.x Chin, 2003, Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy, J Neurol Sci, 210, 19, 10.1016/S0022-510X(03)00010-8 Vallat, 2003, Interferon beta-1a as an investigational treatment for CIDP, Neurology, 60, S23, 10.1212/WNL.60.8_suppl_3.S23 Donaghy, 1994, Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin, J Neurol Neurosurg Psychiatry, 57, 778, 10.1136/jnnp.57.7.778 Kuwabara, 2002, Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy, J Neurol Neurosurg Psychiatry, 72, 37, 10.1136/jnnp.72.1.37 Mygland, 2005, Onset and course of chronic inflammatory demyelinating polyneuropathy, Muscle Nerve, 31, 589, 10.1002/mus.20297 Hattori, 2001, Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy, J Neurol Sci, 184, 57, 10.1016/S0022-510X(00)00493-7 Kuwabara, 2006, Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases, J Neurol Neurosurg Psychiatry, 77, 66, 10.1136/jnnp.2005.065441